The Research Institute at Nationwide Children’s Hospital · company speakers →
Dr. Dean Lee will discuss the growth in interest and progress in adoptive transfer of NK cells over the past few years, particularly given their low risk of alloreactivity, and therefore potential as an off-the-shelf therapeutic. NK cells have been much more difficult to genetically modify than T cells, but several recent advances have solved this, making genetically engineered off-the-shelf products possible.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →